Compare Recursion Pharmaceuticals Inc (RXRX) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Zillow Group Inc Class A — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: Zillow Group Inc Class A is far larger — about 4.9× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| RXRX | ZG | |
|---|---|---|
Market Cap | $1.53B | $7.54B |
Sector | Health | Media |
52-Week High | $6.79 | $86.76 |
52-Week Low | $2.84 | $29.14 |
Enterprise Value | $946.50M | $7.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (ZG) trades at $31.80, down 5.67% over 24 hours, amid a bearish technical signal and negative news flow. The company reported revenue of $2.58B in 2025 with a net income of $23M, marking a return to profitability after losses in prior years. However, a high P/E ratio of 131.36 suggests premium valuation, while recent earnings showed a mix of beats and misses. Multiple law firms have announced securities class action investigations related to an alleged anticompetitive agreement, contributing to investor uncertainty.
The outlook is clouded by legal risks and rich valuation, though analyst consensus remains positive with a $57.80 price target. Upside potential hinges on sustained revenue growth and margin expansion, but downside risks include litigation outcomes and competitive pressures. Investors should weigh the strong analyst buy rating against fundamental headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
